LEROY, Bernard, Mandy L. BALLINGER, Fanny BARAN-MARSZAK, Gareth L. BOND, Antony BRAITHWAITE, Nicole CONCIN, Lawrence A. DONEHOWER, Wafik S. EL-DEIRY, Pierre FENAUX, Gianluca GAIDANO, Anita LANGEROD, Eva HELLSTROM-LINDBERG, Richard IGGO, Jacqueline LEHMANN-CHE, Phuong L. MAI, David MALKIN, Ute M. MOLL, Jeffrey N. MYERS, Kim E. NICHOLS,
Šárka POSPÍŠILOVÁ, Patricia ASHTON-PROLLA, Davide ROSSI, Sharon A. SAVAGE, Louise C. STRONG, Patricia N. TONIN, Robert ZEILLINGER, Thorsten ZENZ, Joseph F. FRAUMENI, Peter E. M. TASCHNER, Pierre HAINAUT a Thierry SOUSSI. Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice.
Cancer Research. PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2017, roč. 77, č. 6, s. 1250-1260. ISSN 0008-5472. Dostupné z: https://dx.doi.org/10.1158/0008-5472.CAN-16-2179.